No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma Register

Annals of the rheumatic diseases, 2024-04, p.ard-2024-225758 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2024-225758 ;PMID: 38653532

Digital Resources/Online E-Resources